Effects of LX4211, a Dual SGLT1/SGLT2 Inhibitor, Plus Sitagliptin on Postprandial Active GLP-1 and Glycemic Control in Type 2 Diabetes
Titel:
Effects of LX4211, a Dual SGLT1/SGLT2 Inhibitor, Plus Sitagliptin on Postprandial Active GLP-1 and Glycemic Control in Type 2 Diabetes
Auteur:
Zambrowicz, Brian Ding, Zhi-Ming Ogbaa, Ike Frazier, Kenny Banks, Phillip Turnage, Anne Freiman, Joel Smith, Melinda Ruff, Dennis Sands, Arthur Powell, David
Verschenen in:
Clinical therapeutics
Paginering:
Jaargang 35 (2013) nr. 3 pagina's 2.849999728E9 p.